Please read and agree to the
terms and conditions
of this site.
I agree
Stream
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
new york blog main
new york top stories
pfizer
2
×
akcea therapeutics
anylam pharmaceuticals
array biopharma
astrazeneca
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cardiomyopathy
drugs
fda
inotersen
kinase inhibitors
melanoma
national
national cancer institute
national organization for rare disorders
national top stories
neurofibromatosis type 1 (nf1)
neuropathy
new york
olaparib (lynparza)
onpattro
patisiran
rare diseases
san diego blog main
san diego top stories
selumetinib
tafamidis
tegsedi
thyroid cancer
transthyretin amyloidosis
What
approved
2
×
drug
fda
genetic
rare
2
×
ago
akcea
alnylam
amyloidosis
astrazeneca
attr
available
battle
block
debilitating
designed
disease
disorder
growth
inherited
leads
medicines
neurofibromatosis
nf
nod
oks
patients
pfizer
sets
transthyretin
treatment
tumor
type
wins
year
Language
unset
Current search:
pfizer
×
approved
×
rare
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}